Advertisement

Topics

Pulmatrix and Cipla collaborate to develop asthma drug

19:00 EDT 16 Apr 2019 | Pharmaceutical Technology

Pulmatrix and Cipla Technologies have signed a definitive agreement to jointly develop and commercialise Pulmazole to treat allergic bronchopulmonary aspergillosis...
Read More...

The post Pulmatrix and Cipla collaborate to develop asthma drug appeared first on Pharmaceutical Technology.

Original Article: Pulmatrix and Cipla collaborate to develop asthma drug

NEXT ARTICLE

More From BioPortfolio on "Pulmatrix and Cipla collaborate to develop asthma drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...